Physicians’ financial ties with the pharmaceutical industry: A critical element of a formidable marketing network

Conflicts of Interest: Challenges and Solutions in Business, Law, Medicine, and Public Policy

Volumn , Issue , 2005, Pages 133-141

  Kassirer, Jerome P ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79958252809     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511610332.010     Document Type: Chapter

References (20)

1. Angell, M., & Relman, A. S. (2002). America’s other drug problem. The New Republic, December 16.
2. Anonymous. About NISE: National Initiative in Sepsis Education, 2002. Accessed December 5, 2002, at http://nise.cc/about.php3.
3. Anonymous. Advances in Sepsis Online.Vol. 2003: Lilly Critical Care and Remedica Publishing Ltd. Accessed July 2, 2003, at http://www.sepsis.remedica.com/journal.asp?page = home.
4. Anonymous.American Thoracic Society. ATS 2002 Conference Symposia excerpts, Atlanta, GA, 2002. Medical Association Communications.
5. Anonymous. Lipidhealth. Lipid Management Newsletter. Vol. 2002: Thomson Professional Postgraduate Services.
6. Anonymous. Emerging science of lipid management. Lipid Letter. Vol. 2, 2002:1.
7. Anonymous. Lipids Online. Editorial Board Web Page. Vol. 2002. Accessed Dec 6, 2002 at http:www.lipidsonline.org/site/editorial.cfm.
8. Anonymous. Faculty Disclosure. Managing HIT: Preventing Life- and Limb-Threatening Thrombosis Slide Kit: University of Pennsylvania School of Medicine, 2002.
9. Anonymous. Nocturnal GERD. Bethesda, MD: American Gastroenterological Association, 2002.
10. Barabasi, A.-L. (2003). Linked: How everything is connected to everything else and what it means for business, science, and everyday Life. New York: Plume (Penguin Group).
11. Campbell, E. G., Louis, K. S., & Blumenthal, D. (1998). Looking a gift horse in the mouth: Corporate gifts supporting life sciences research. Journal of the American Medical Association, 279, 995–999.
12. Cauchon, D. (2000). FDA advisers tied to industry. USA Today, September 25, 1A.
13. Crews, J. C. (2002). Multimodal pain management strategies for office-based and ambulatory procedures. Journal of the American Medical Association, 288, 629–632.
14. CRUSADE Executive Committee (2002). A practical guide to understanding the 2002 ACC/AHA guidelines for the management of patients with non-STsegment elevation acute coronary syndromes. Duke Clinical Research Institute, 1–42.
15. Desnick, R. J., Brady, R., Barranger, J., et al. (2003). Fabry Disease, and underrecognized multisystemic disorder: Expert recommendations for diagnosis, management, and enzyme replacement therapy. Annals of Internal Medicine, 138, 338–346.
16. Drazen, J. M., & Curfman G. D. (2002). Financial associations of authors. New England Journal of Medicine, 346, 1901–1902.
17. Kleinschmidt, K., Miller, A., Polack, C., Bosker, G. (Eds.). (2002). Quick consult: Guide to clinical trials in thrombosis management. In: Atlanta: American Health Consultants, 2002:452.
18. Popeo, D. J., & Samp, R. A. (2003). Comments of the Washington Legal Foundation to the Accreditation Council for Continuing Medical Education Concerning Request for Comments on the January 14, 2003 Draft “Standards to Ensure the Separation of Promotion From Education Within the CME Activities of ACCME Accredited Providers”: Washington Legal Foundation, 1–11.
19. Stelfox, H. T., Chua, G., O’Rourke, K., & Detsky, A. S. (1998). Conflict of interest in the debate over calcium-channel antagonists. New England Journal of Medicine, 338, 101–106.
20. Watts, D. J. (2003). Six degrees: The science of a connected age. New York: W. W. Norton.